WHO ICTRP trial
The effect of somatostatin, cycloxygenase-2, HBV X protein and portal…
ChiCTR-OO-08000153 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-OO-08000153 |
|---|---|
| Public title | The effect of somatostatin, cycloxygenase-2, HBV X protein and portal hypertention on the development of hepatocellular carcinoma |
| Scientific title | The effect of somatostatin, cycloxygenase-2, HBV X protein and portal hypertention on the development of hepatocellular carcinoma |
| Primary sponsor | West China Hospital, Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Other |
| Countries | China |
| Conditions | Chronic hepatitis B, HBV related cirrhosis, hepatocellular carcinoma |
| Interventions | Normal liver tissue and blood:Detect SST, SSTR, COX-2, HBx, AFP, etc.;Adjacent liver tissue of HCC and blood:Detect SST, SSTR, COX-2, HBx, AFP, etc.;Chronic hepatitis tissue and blood:Detect SST, SSTR, COX-2, AFP etc.;Cirrhotic liver tissue… |
| Registration date | Jul 21, 2008 |
| Target size | Normal liver tissue and blood:20;Adjacent liver tissue of HCC and… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: